Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Title Published Pages Price
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 73 USD 2,000.00
Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 53 USD 2,000.00
Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 53 USD 3,500.00
Ornithine-Transcarbamylase Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 61 USD 2,000.00
Radiodermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 54 USD 2,000.00
RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 117 USD 3,500.00
Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 63 USD 2,000.00
Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 79 USD 2,000.00
Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 106 USD 2,000.00
Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 246 USD 2,000.00
Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 504 USD 2,500.00
Sicca Syndrome (Sjogren) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 120 USD 2,000.00
Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 55 USD 2,000.00
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 574 USD 2,500.00
Graves Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 36 USD 2,000.00
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 99 USD 2,000.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: Landscape Analysis of Technologies, Targets, Business & Financing Nov 10 2022 418 USD 2,500.00
Global Cancer Vaccine Partnering Terms and Agreements 2010-2022 Nov 1 2022 250 USD 3,995.00
Global Ophthalmics Partnering 2014-2022: Deal trends, players and financials Nov 1 2022 400 USD 3,995.00
Global Artificial Intelligence (AI) Partnering Terms and Agreements 2010 to 2022 Nov 1 2022 500 USD 3,995.00
Global Stem Cell Partnering Terms and Agreements 2010-2022 Nov 1 2022 450 USD 3,995.00
Global Biomarker Partnering Terms and Agreements 2010-2022: Deal trends, players and financials Nov 1 2022 900 USD 3,995.00
Global Antibiotics Partnering Terms and Agreements 2010 to 2022 Nov 1 2022 300 USD 3,995.00
Global Drug Delivery Partnering Terms and Agreements 2015-2022 Nov 1 2022 950 USD 3,995.00
Global Infectious Vaccines Partnering Terms and Agreements 2015 to 2022: Deal trends, players and financials Nov 1 2022 450 USD 3,995.00
Global Cancer Diagnostics Partnering Terms and Agreements 2015-2022 Nov 1 2022 600 USD 3,995.00
Global Respiratory Partnering 2010-2022: Deal trends, players and financials Nov 1 2022 650 USD 3,995.00
Global Vaccine Partnering Terms and Agreements 2015-2022: Deal trends, players and financials Nov 1 2022 600 USD 3,995.00
Global Orphan Diseases Partnering 2010-2022: Deal trends, players and financials Nov 1 2022 200 USD 3,995.00
Global In Vitro Diagnostics Partnering Terms and Agreements 2010-2022 Nov 1 2022 550 USD 3,995.00
Global Precision Medicine Partnering Terms and Agreements 2015-2022 Nov 1 2022 1100 USD 3,995.00
Global Companion Diagnostics Partnering Terms and Agreements 2010-2022 Nov 1 2022 350 USD 3,995.00
Global Antibody Partnering Terms and Agreements 2015-2022 Nov 1 2022 1200 USD 3,995.00
Global Diagnostics Partnering Terms and Agreements 2015-2022 Nov 1 2022 1700 USD 3,995.00
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022 Nov 1 2022 400 USD 3,995.00
Ankylosing Spondylitis (Bekhterev's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 140 USD 2,000.00
Anaplastic Oligoastrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 34 USD 2,000.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 113 USD 3,500.00
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 643 USD 2,500.00
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 204 USD 2,000.00
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 53 USD 3,500.00
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 210 USD 2,000.00
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 1814 USD 2,000.00
Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 35 USD 3,500.00
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 548 USD 2,500.00
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 628 USD 2,500.00
Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 41 USD 3,500.00
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 94 USD 2,000.00
Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 64 USD 2,000.00
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Oct 31 2022 90 USD 2,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected